Renske ten Ham is an assistant professor at UMC Utrecht, specializing in health economics and health technology assessment of Regenerative Medicines. Her experience includes research at UCSF, Dutch Medicines Evaluation Board, and the Dutch National Health Care Institute (ZIN). She is a recipient of the Greiner Award, University of York Centre for Health Economics Fellowship, and NWO VENI.

At UMC Utrecht, she leads the Health Economics Regenerative Medicines group and serves on ZIN’s Scientific Advisory Board. Her research focusses on payment models, development cost, (early) economic evaluations and methods development.